共查询到20条相似文献,搜索用时 15 毫秒
1.
Ventricular Oversensing: 总被引:8,自引:1,他引:7
SLAWOMIR WERETKA JOCHEN MICHAELSEN RUEDIGER BECKER CHRISTOPH A. KARLE FREDERIK VOSS THOMAS HILBEL BRIGITTE R. OSSWALD† MALTE L. BAHNER‡ JULIA C. SENGES WOLFGANG KUEBLER WOLFGANG SCHOELS 《Pacing and clinical electrophysiology : PACE》2003,26(1P1):65-70
WERETKA, S., et al. : Ventricular Oversensing: A Study of 101 Patients Implanted with Dual Chamber Defibrillators and Two Different Lead Systems . Modern dual chamber ICD systems are able to overcome various sensing problems. However, improvement of their performance is still required. The aim of this study was to assess the sensing function in 101 consecutive patients (84 men, 17 women; mean age 63 ± 12 years; mean follow-up 24 ± 4 months) implanted with dual chamber defibrillators and integrated (IB) or dedicated bipolar (DB) lead systems. Follow-up data were analyzed for the presence of ventricular oversensing. Oversensing occurred in 25 (25%) patients, significantly more frequent in patients implanted with IB compared to DB lead systems (21/52 vs 4/49, P = 0.0002). Patients with cardiomyopathies (CMs) were more prone to sensing malfunctions than patients with no CM (12/30 vs 13/71, P = 0.04). T wave oversensing (n = 14), respirophasic ventricular oversensing (n = 4), and P wave oversensing (n = 6) were the most common pitfalls of ventricular sensing. P wave oversensing was unique to the IB lead system. CT scans performed in these patients disclosed the position of the RV coil to be proximal to the tricuspid area. Four patients received inappropriate ICD shocks due to oversensing. In all but two patients who received lead revision, oversensing was resolved by noninvasive means. In conclusion: (1) ventricular oversensing is a common problem occurring in up to 25% of patients with dual chamber ICDs; (2) P wave oversensing is a ventricular sensing problem affecting function of 11% of dual chamber devices with IB lead systems; (3) IB leads are significantly more susceptible to T wave and P wave oversensing than DB leads; and (4) patients with cardiomyopathies are more prone to oversensing than patients with other heart diseases. (PACE 2003; 26[Pt. I]:65–70) 相似文献
2.
Implantable Cardioverter Defibrillator Proarrhythmia: Case Report and Review of the Literature 总被引:3,自引:0,他引:3
TODD J. COHEN WALTER W. CHIEN KEITH G. LURIE MICHAEL A. LEE MICHAEL D. LESH MELVIN M. SCHEINMAN JERRY C. GRIFFIN 《Pacing and clinical electrophysiology : PACE》1991,14(9):1326-1329
A 31-year-old man who received an automatic cardioverter defibrillator subsequently underwent exercise testing. During exercise, a sinus tachycardia resulted above his device detect rate prompting two shocks, the second of which produced an unstable polymorphous ventricular tachycardia. In this article, we review the literature on automatic cardioverter defibrillator-induced ventricular tachyarrhythmias as well as the management of exercise testing in patients with these devices. 相似文献
3.
Pacing Induced Ventricular Fibrillation in Internal Cardioverter Defibrillator Patients: A New Form of Proarrhythmia 总被引:1,自引:0,他引:1
Current model internal cardioverter defibrillators (ICDs) have cardioversion, defibrillation, pacemaker, and telemetry function. Telemetry documents arrhythmia and facilitates therapeutic adjustments. We report two cases of pacing induced VF terminated by the defibrillator, with the device responsible for both initiation and correction of the arrhythmia. 相似文献
4.
The Potential Usage of Dual Chamber Pacing in Patients with Implantable Cardioverter Defibrillators 总被引:4,自引:0,他引:4
PATRICIA J.M. BEST DAVID L. HAYES MARSHALL S. STANTON 《Pacing and clinical electrophysiology : PACE》1999,22(1):79-85
Bradycardia support by ICDs has been limited to fixed rate, ventricular pacing. Concomitant placement of a pacemaker and an ICD exposes a patient to potentially life-threatening device interactions. ICDs capable of dual chamber pacing have recently become available. The number of ICD recipients who stand to benefit from the addition of dual chamber pacing is debated, but no data have addressed this question. This retrospective study analyzed all patients who received nonthoractomy ICD system placement at the Mayo Clinic in Rochester, MN between March 1991 and October 1996 in order to determine the proportion of patients in whom a dual chamber pacing ICD may be indicated. Definitions: (1) Definitely indicated = pacemaker present at ICD implant or NASPE Class I pacing indication; (2) Probably indicated = NASPE Class II pacing indication, NYHA Functional Class III or IV, or history of systolic congestive heart failure; (3) Possibly indicated = history of paroxysmal atrial fibrillation or an ejection fraction ≤ 20%. The results were that nonthoracotomy ICDs were placed in 253 patients. A dual chamber ICD would have been definitely indicated in 11% of the study group, probably indicated in 28%, and possibly indicated in 14%. Chronic atrial fibrillation was present at ICD implant in 6.7% of patients and developed in 0.9%/yr during follow-up. The addition of dual chamber pacing to ICDs stands to potentially benefit approximately half (53%) of ICD recipients. These data do not address all patients who may benefit from dual chamber sensing. 相似文献
5.
Study of Precursors of Ventricular Tachycardia from Data Stored in the Memory of a Dual Chamber Implantable Cardioverter Defibrillator 总被引:1,自引:0,他引:1
ANTOINE LEENHARDT NICOLAS SADOUL† PHILIPPE MABO‡ SALEM KACET§ THOMAS LAVERGNE NADIR SAOUDI# NICOLAS ISCOLO 《Pacing and clinical electrophysiology : PACE》2003,26(7P1):1454-1460
6.
7.
PAUL KNOPS B.Sc . DOMINIC A. M. J. THEUNS Ph .D. JAN C. J. RES M.D. Ph .D. LUC JORDAENS M.D. Ph .D. 《Pacing and clinical electrophysiology : PACE》2009,32(10):1276-1285
Introduction: Information about implantable cardioverter‐defibrillator (ICD) longevity is mostly calculated from measurements under ideal laboratory conditions. However, little information about longevity under clinical circumstances is available. This survey gives an overview on ICD service times and generator replacements in a cohort of consecutive ICD patients. Methods: Indications for replacement were classified as a normal end‐of‐service (EOS), premature EOS, system malfunction, infection and device advisory, or recall actions. From the premature and normal EOS group, longevity from single‐chamber (SC), dual‐chamber (DC), and cardiac resynchronization therapy defibrillator (CRT‐D), rate‐responsive (RR) settings, high output (HO) stimulation, and indication for ICD therapy was compared. Differences between brands were compared as well. Results: In a total of 854 patients, 203 ICD replacements (165 patients) were recorded. Premature and normal EOS replacements consisted of 32 SC, 98 DC and 24 CRT‐D systems. Longevity was significantly longer in SC systems compared to DC and CRT‐D systems (54 ± 19 vs. 40 ± 17 and 42 ± 15 months; P = 0.008). Longevity between non‐RR (n = 143) and RR (n = 11) settings was not significantly different (43 ± 18 vs. 45 ± 13 months) as it also was not for HO versus non‐HO stimulation (43 ± 19 vs. 46 ± 17 months). Longevity of ICDs was not significantly different between primary and secondary prevention (42 ± 19 vs. 44 ± 18 months). The average longevity on account of a device‐based EOS message was 43 ± 18 months. Average longevity for Biotronik (BIO, n = 72) was 33 ± 10 months, for ELA Medical (ELA, n = 12) 44 ± 17 months, for Guidant (GDT, n = 36) 49 ± 12 months, for Medtronic (MDT, n = 29) 62 ± 22 months, and for St. Jude Medical (SJM, n = 5) 31 ± 9 months (P < 0.001). Conclusion: SC ICD generators had a longer service time compared to DC and CRT‐D systems. No influence of indication for ICD therapy and HO stimulation on generator longevity was observed in this study. MDT ICDs had the longest service time. 相似文献
8.
9.
LUKAS R.C. DEKKER TIM A.M. SCHRAMA FRANS H.L. STEINMETZ RAYMOND TUKKIE 《Pacing and clinical electrophysiology : PACE》2004,27(6P1):833-834
We describe a case of potentially fatal undersensing of VF by a third generation ICD with predetermined automatic gain control. In this patient, ventricular sensing was optimal, as R wave amplitudes during sinus rhythm were at least 16 mV. Cyclical, high amplitude signals during VF elevated the sensing floor to such an extent that complete undersensing of subsequent lower amplitude local electrograms occurred. This led to bradypacing and complete ICD therapy failure. Therefore, high R wave amplitudes during sinus rhythm do not warrant flawless sensing during VF. (PACE 2004; 27[Pt. I] 833–834) 相似文献
10.
HEMAL M. NAYAK LANA TSAO FRANCESCO SANTONI-RUGIU J. ANTHONY GOMES DAVENDRA MEHTA 《Pacing and clinical electrophysiology : PACE》1997,20(11):2864-2866
Analysis of stored electrograms from bipolar far-field electrodes is considered to be useful in differentiating supraventricular from ventricuiar arrhythmias. A case of inappropriate ICD shocks for sinus tachycardia is presented whereby successive shocks caused marked widening of the ventricuiar electrograms. Analysis of these stored electrograms, recorded from far-field bipolar electrodes, gave the false impression of ventricuiar tachycardia. The widening was due to the current of injury effects, probably a consequence of the large amount of intervening myocardium between the bipoies. While analyzing recordings from far-field bipolar electrodes is generally useful, it is not always reliable, for changes in electrogram morphoiogy, reiative to baseline rhythm, may result from other factors like current of injury. 相似文献
11.
HUAGUI G. LI RANJAN K. THAKUR RAYMOND YEE GEORGE J. KLEIN 《Pacing and clinical electrophysiology : PACE》1994,17(12):2304-2306
Incorporation of atrial electrograms in the tachycardia detection algorithm may improve tachyarrhythmia discrimination by ICDs but retrograde ventriculoatrial (VA) conduction over the AV node during ventricular tachyarrhythmia may be problematic. The present study analyzed VA conduction characteristics in 66 ICD patients who had evaluation of the VA conduction system by electrophysiological studies before implant. VA conduction was demonstrated in patients during ventricular decremental stimulation. Forty patients had inducible sustained monomorphic VT. The minimum cycle length maintaining 1:1 VA conduction during ventricular stimulation was longer than the cycle of VT in every patient (496 ±100 msec vs 320 ± 81 msec; P < 0.01). Occasional VA conduction during VT was observed in five patients and one patient had 2:1 VA conduction during induced VT. No patient had 1:1 VA conduction during VT. We conclude that brisk VA conduction is uncommon and 1:1 VA conduction during VT is rare in ICD recipients. VA conduction is unlikely to complicate the incorporation of atrial electrograms into tachyarrhythmia detection algorithms. 相似文献
12.
BERNHARD STROHMER JOHANN MERMI† EDUARDO CASTELLANOS‡ HARALD MAYR£ JASWINDER GILL§ ANTONIO ASSO ABADIA MARTIN KUEHL†† CHRISTIAN WOLPERT‡‡ 《Pacing and clinical electrophysiology : PACE》2005,28(S1):S249-S254
Recent observations suggest that frequent dual-chamber pacing in recipients of implantable cardioverter defibrillators (ICD) may adversely influence clinical outcomes. This prospective, multicenter study examined the relationship between the frequency of atrial (%AP) and ventricular pacing (%VP) and the incidence of atrial (AT) and/or ventricular tachyarrhythmias (VT) in a standard ICD population. A total of 141 consecutive patients with primary and secondary ICD indications were studied. Continuous arrhythmia detection with a dual-chamber ICD revealed paroxysmal AT in 60 (43%) and VT in 72 (51%) patients within 6 months of device implantation. Far-field oversensing of ventricular signals occurred in 13% of all "atrial tachy response" mode switches. Without adjustment for covariates, a higher %AP was associated with an increased incidence of AT (P < 0.05). However, this association remained only weakly significant after adjustment for covariates using a multivariate model. High New York heart failure functional classes correlated significantly with AT (P = 0.02) and VT (P = 0.007). Rate-modulated pacing, programmed in 1/3 of patients, correlated with occurrence of AT (P = 0.006), but not with occurrence of VT. With respect to dual-chamber pacing, a %AP ≥ 48% combined with a %VP > 40% was associated with an increased probability for VT. In conclusion, AT and VT occurred frequently within 6 months after dual-chamber ICD implantation. High rates of DDD/R stimulation were associated with a trend toward higher incidence of AT, VT, or both. 相似文献
13.
MICHAEL BLOCK DIETER HAMMEL DIRK BöCKER MARTIN BORGGREFE THOMAS BUDDE FRANK ISBRUCH HANS H. SCHELD GÜNTER BREITHARDT 《Pacing and clinical electrophysiology : PACE》1996,19(2):207-214
The volume of current implantable cardioverter defibrillators (ICD) is not convenient for pectoral implantation. One way to reduce the size of the pulse generator is to find a more effective defibrillation pulse waveform generated from smaller volume capacitors. In a prospective randomized crossover study we compared the step-down defibrillation threshold (DFT) of a standard biphasic waveform (STD), delivered by two 250-μF capacitors connected in series with an 80% tilt, to an experimental biphasic waveform delivered by a single 450μF capacitor with a 60% tilt. The experimental waveform delivered the same energy with a lower peak voltage and a longer duration (LVLDj. Intraopera-tively, in 25 patients receiving endocardial (n = 12) or endocardial-subcutaneous array (n = 13) defibrillation leads, the DFT was determined for both waveforms. Energy requirements did not differ at DFT for the STD and LVLD waveforms with the low impedance (32 ± 4Ω) endocardial-subcutaneous array defibrillation lead system (6.4 ± 4.4 J and 5.9 ± 4.2 J, respectively) or increased slightly (P - 0.06) with the higher impedance (42 ± 4 Ω) endocardial lead system (10.4 ± 4.6 J and 12.7 ± 5.7 /. respectively), However, the voltage needed at DFT was one-third lower with the LVLD waveform than with the STD waveform for both lead systems (256 ± 85 V vs 154 ± 53 V and 348 ± 76 V vs 232 ± 54 V, respectively). Thus, a single capacitor with a large capacitance can generate a defibrillation pulse with a substantial lower peak voltage requirement without significantly increasing the energy requirements. The volume reduction in using a single capacitor can decrease ICD device size. 相似文献
14.
RICHARD G. SHEAHAN PAUL DORIAN MARY POLUDNIKIEWICZ DAVID NEWMAN 《Pacing and clinical electrophysiology : PACE》1997,20(6):1704-1707
This case report concerns an adverse device-device interaction between a replacement ICD and a dual chamber rate responsive pacemaker. It was observed that subtle changes in the design of sensing circuits between an older first-generation ICD and the newer third-generation ICD device led to unexpected and dramatic changes in the interactive behavior of a dual device system. The new ICD was connected to chronically implanted hardware. The sensing behavior of the newer ICD included a shorter time constant in the decay of the automatic gain control function, resulting in triple sensing of both the atrial and ventricular paced stimuli and the evoked QRS complex. Physicians should be aware of new design changes in the future so as to anticipate such interactions. In the setting of rapidly changing technology, extra caution must be exercised when choosing to implant two devices in the same patient. 相似文献
15.
FARIBORZ AKBARZADEH M.D. BABAK KAZEMI M.D. LEILI POURAFKARI M.D. 《Pacing and clinical electrophysiology : PACE》2010,33(3):372-376
A 23‐year‐old woman with obstructive hypertrophic cardiomyopathy and history of frequent unexplained syncope had undergone implantable cardioverter defibrillator implantation. She had experienced frequent inappropriate shocks since implantation due to T‐wave oversensing. After one of the syncopal attacks, she was found to have an atrioventricular (AV)‐reentrant tachycardia, induced by a high‐voltage shock, with rapid degeneration to atrial fibrillation and then ventricular fibrillation. The AV‐reentrant tachycardia was believed to be the cause of both syncopal attacks and inappropriate shocks. The patient has been asymptomatic after ablation of the accessory pathway. To the best of our knowledge, this is the first report of induction of an AV‐reentrant tachycardia by a high‐voltage implantable cardioverter defibrillator shock. (PACE 2010; 33:372–376) 相似文献
16.
MARTIN FROMER JÜRG SCHLÄPFER ADAM FISCHER LUKAS KAPPENBERGER 《Pacing and clinical electrophysiology : PACE》1991,14(8):1288-1298
Ten consecutive patients (mean age 57.9 +/- 7.6 years) were treated with an investigational tachyarrhythmia control device, the implantable Medtronic Pacer-, Cardioverter-, Defibrillator model 7216A or 7217B. All patients had coronary artery disease with old myocardial infarctions and presented hemodynamically significant sustained ventricular tachyarrhythmias not suppressed by antiarrhythmic drug therapy and unrelated to acute myocardial infarction. In two patients a nonthoracotomy lead system was implanted. Lowest effective defibrillation energy ranged from 5 to 18 joules (mean 12.2 +/- 4 joules) for the epicardial bielectrode systems and were 15 and 18 joules for the nonthoracotomy lead system implants. The postoperative periods were unremarkable. Follow-up ranged from 7 to 19 months (mean 13.8 +/- 4.5 months). Spontaneous tachyarrhythmia episodes were detected and treated by the device in six patients, five of them received staged therapies. No deaths occurred and no hospital admissions were necessary for device related or ventricular tachyarrhythmia related complications. In conclusion, this integrated device represents a major step toward the development of a universal ventricular arrhythmia control device. 相似文献
17.
Suzuki T Shiga T Kuwahara K Kobayashi S Suzuki S Nishimura K Suzuki A Ejima K Manaka T Shoda M Ishigooka J Kasanuki H Hagiwara N 《Pacing and clinical electrophysiology : PACE》2010,33(12):1455-1461
Background: It is unclear whether depression persists in patients with implantable cardioverter defibrillators (ICDs). We evaluated the prevalence and persistence of depression in ICD patients over a 2‐year period. Methods: The study included 90 consecutively hospitalized patients. Patients underlying heart disease was 24% coronary artery disease, 29% idiopathic dilated cardiomyopathy, 24% hypertrophic cardiomyopathy, 13% idiopathic VF/long QT syndrome and miscellaneous conditions 11%. A secondary indication for ICD implantation was present in 20 patients. All patients completed the Zung Self‐Rating Depression Scale (SDS) at study baseline and at the their routine follow‐up visit 2 years after the baseline questionnaire. Delivery of ICD therapies was tracked throughout the 2 years. Results: Depression, indicated by a Zung SDS index score exceeding 60, was present in 29 (32%) of patients at study baseline. Depression was present in 11/51 (21%) patients scheduled to undergo ICD implantation, 2/2 (100%) patients whose device was upgraded to a CRT‐D, 3/14 (21%) patients who had undergone pulse generator replacement, 7/14 (50%) patients who experienced electrical storm and 6/9 (66%) patients hospitalized with acute decompensated heart failure. NYHA functional class III was significantly associated with depression at baseline (HR 6.7, 95% CI 1.68–27.2, p = 0.0007). No differences were noted for female gender, demographics, β‐blocker use, or LVEF ≤35% (p = ns). Depression was present in 25 (28%) of patients at 2 years follow‐up, persisting in 21 (72%) of patients whose Zung SDS scores were elevated at baseline. The median time from ICD shock therapy to completion of the 2 year questionnaire was 9 months (range, 1–22). Patients who were depressed (9/25, 36%) experienced more shocks than non‐depressed patients (6/65, 9%) after 2 years (p = 0.002). Conclusions: Depression is not uncommon among patients who meet criteria for ICD implantation and persists over time particularly when functional status is impaired. Depression is associated with a higher incidence shock therapy. (PACE 2010; 33:1455–1461) 相似文献
18.
VLADIMIR TURKISHER ISRAEL PRIEL MICHAEL DAN 《Pacing and clinical electrophysiology : PACE》1997,20(9):2268-2270
Infection of an implantable cardioverter defibrillator developed 2 weeks after implantation, presenting with fever, swelling, redness, and tenderness of the skin above the generator site. A cloxacillin resistant coagulase-negative staphylococcus was repeatedly cultured from the abdominal wall pocket fluid. The infection was successfully treated with a combination of two antibiotics, fusidic acid and rifampin, given orally for 3 months. Although the device was not removed, infection did not recur during a 24-month follow-up. 相似文献
19.
Israel CW Grönefeld G Iscolo N Stöppler C Hohnloser SH 《Pacing and clinical electrophysiology : PACE》2001,24(2):183-190
Although the addition of atrial sensing in dual chamber ICDs may improve the ability of the device to discriminate between supraventricular (SVT) and ventricular tachycardia (VT), atrial sensing errors may also negatively affect tachycardia classification. This prospective study evaluated the incidence of atrial sensing errors in a dual chamber ICD and their impact on VT/SVT discrimination. In 145 patients, a dual chamber ICD (Defender) was implanted. Analysis of 1,241 tachycardia episodes stored during a mean follow-up of 14+/-8 months revealed atrial sensing errors in 817 (66%) episodes. Upon expert review, device-based classification was confirmed in 509 (98%) of 522 SVT episodes. No false device-based SVT classification was related to atrial sensing errors. Of 719 episodes classified as VT by the device, 645 (90%) were confirmed. There were 74 episodes of false-positive VT detection. Of these, 63 were related to atrial sensing errors: atrial undersensing in 58 (92%) and atrial oversensing in 5 (8%) episodes. Atrial sensing errors led to incorrect VT/SVT discrimination in 51 (4%) of 1,241 episodes. Only the occurrence of paroxysmal atrial fibrillation and abdominal site of device implantation showed a significant influence on false VT/SVT discrimination. Atrial sensing errors are frequently encountered in dual chamber ICDs. Due to the VT/SVT discrimination algorithm, atrial sensing errors only led to misclassification in 4 % of all episodes, mainly due to atrial undersensing. No VT underdetection due to atrial oversensing occurred. 相似文献
20.
Experience with a dual chamber implantable defibrillator 总被引:3,自引:0,他引:3
Kühlkamp V Wilkoff BL Brown AB Volosin KJ Hügl BJ Stafford W Cameron DA 《Pacing and clinical electrophysiology : PACE》2002,25(7):1041-1048
An implantable defibrillator with dual chamber pacing may have advantages for pacing, sensing, and detection of brady- and tachyarrhythmias. This study evaluates the safety and performance of a dual chamber implantable cardioverter defibrillator that incorporates an algorithm to discriminate supraventricular from ventricular arrhythmias. The 300 patients in this study had the device implanted for the following indications: ventricular tachycardia (47%), sudden cardiac death survivorship (51%), and prophylactic implants (2%). Patients received dual chamber pacing for accepted bradyarrhythmic (51.7%) or investigational indications. During a mean follow-up period of 1.7 months a total of 1,092 arrhythmia episodes in 96 patients were fully documented in the device memory: 66 patients experienced a total of 796 ventricular tachyarrhythmia episodes and 42 experienced a total of 296 supraventricular episodes. The device appropriately detected 100% of sustained ventricular tachyarrhythmias while reducing the inappropriate detection of supraventricular tachyarrhythmias by 72% compared to single chamber rate only detection. The positive predictive value was 90.5% for ventricular tachyarrhythmia detection in episodes that exceeded the tachycardia detection rate. Adverse events observed in at least 2% of the patients were incisional pain (22%), inappropriate ventricular detection (7%), atrial lead dislodgement (4%), atrial oversensing/undersensing (3%), hematoma (3%), incessant ventricular tachyarrhythmia (2%), and pneumothorax (2%). There were 13 deaths, none of which were attributed to device failure. The Gem DR is safe and effective for the detection and treatment of ventricular tachyarrhythmias. The dual chamber detection algorithm appropriately recognized supraventricular tachycardia with rapid ventricular rates 72% of the time while maintaining 100% detection of sustained ventricular tachyarrhythmias. 相似文献